The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.

[1]  Aiqing He,et al.  Genetic Regulation of Adipose Gene Expression and Cardio-Metabolic Traits. , 2017, American journal of human genetics.

[2]  G. Latkovskis,et al.  Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels , 2016, Experimental and Clinical Endocrinology & Diabetes (Barth).

[3]  S. Hazen,et al.  Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.

[4]  Donald J L Jones,et al.  Trimethylamine N-oxide and prognosis in acute heart failure , 2016, Heart.

[5]  Nicholette D. Palmer,et al.  Tissue-Specific and Genetic Regulation of Insulin Sensitivity-Associated Transcripts in African Americans. , 2016, The Journal of clinical endocrinology and metabolism.

[6]  P. Stenvinkel,et al.  Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease , 2016, PloS one.

[7]  S. Hazen,et al.  Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis , 2015, Cell.

[8]  M. Urashima,et al.  Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study , 2015, Clinical and Experimental Nephrology.

[9]  T. Karlsen,et al.  Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure Running head : Microbiota and heart failure , 2014 .

[10]  Ji Miao,et al.  Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis , 2015, Nature Communications.

[11]  F. Rey,et al.  Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide , 2015, mBio.

[12]  Bin Zhang,et al.  Integrative network analysis reveals different pathophysiological mechanisms of insulin resistance among Caucasians and African Americans , 2015, BMC Medical Genomics.

[13]  Richard G. Lee,et al.  The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. , 2015, Cell reports.

[14]  S. Hazen,et al.  The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. , 2015, Annual review of medicine.

[15]  Enrico Gratton,et al.  In vivo single-cell detection of metabolic oscillations in stem cells. , 2015, Cell reports.

[16]  Richard G. Lee,et al.  Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis[S] , 2015, Journal of Lipid Research.

[17]  Brian J. Bennett,et al.  Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation* , 2014, The Journal of Biological Chemistry.

[18]  W. Atkinson,et al.  Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study , 2014, PloS one.

[19]  D. Muoio,et al.  Metabolic Inflexibility: When Mitochondrial Indecision Leads to Metabolic Gridlock , 2014, Cell.

[20]  S. Hazen,et al.  γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. , 2014, Cell metabolism.

[21]  S. Hazen,et al.  Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. , 2014, Journal of the American College of Cardiology.

[22]  Jie Xu,et al.  Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. , 2014, Journal of bioscience and bioengineering.

[23]  M. Blaser,et al.  Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences , 2014, Cell.

[24]  C. Kahn,et al.  ASC-1, PAT2, and P2RX5 are cell surface markers for white, beige, and brown adipocytes , 2014, Science Translational Medicine.

[25]  S. Hazen,et al.  Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. , 2014, European heart journal.

[26]  B. Cravatt,et al.  The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome. , 2013, Cell reports.

[27]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[28]  Brian J. Bennett,et al.  Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. , 2013, Cell metabolism.

[29]  Eleazar Eskin,et al.  Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. , 2013, Cell metabolism.

[30]  Dheeraj S. Roy,et al.  Synchronous Evolution of an Odor Biosynthesis Pathway and Behavioral Response , 2013, Current Biology.

[31]  F. Vermeylen,et al.  Maternal choline intake alters the epigenetic state of fetal cortisol‐regulating genes in humans , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  B. Spiegelman,et al.  Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human , 2012, Cell.

[33]  P. Wolf,et al.  The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring Cohort. , 2011, The American journal of clinical nutrition.

[34]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[35]  John T. Melchior,et al.  CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance[S] , 2010, Journal of Lipid Research.

[36]  G. Shaw,et al.  Choline and Risk of Neural Tube Defects in a Folate-fortified Population , 2009, Epidemiology.

[37]  P. Turnbaugh,et al.  The core gut microbiome, energy balance and obesity , 2009, The Journal of physiology.

[38]  M. Laakso,et al.  Association of 18 Confirmed Susceptibility Loci for Type 2 Diabetes With Indices of Insulin Release, Proinsulin Conversion, and Insulin Sensitivity in 5,327 Nondiabetic Finnish Men , 2009, Diabetes.

[39]  J. Cashman,et al.  Human flavin-containing monooxygenases. , 2006, Annual review of pharmacology and toxicology.

[40]  F. Bäckhed,et al.  Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[43]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[44]  S. Hazen,et al.  Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus. , 2017, Clinical chemistry.

[45]  J. Heeren,et al.  Adipose tissue browning and metabolic health , 2014, Nature Reviews Endocrinology.

[46]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.